Family Medicine · Dickinson, ND
NPI
1649367343
Since 2006
Specialty
Family Medicine
Code 207Q00000X
Group practices
2
Medicare group memberships
Hospitals
3
Hospital affiliations
33 9th St W
Dickinson, ND, 58601
Phone (701) 483-6017
Groups this clinician bills Medicare through
Medicare paid, 2024
$317K
16,516 services
Medicare patients, 2024
772
Average age 76
Drug cost, 2024
$1.9M
26,896 prescriptions
Company payments, 2025
$817
From 15 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Cory E Rathgeber was code J0897 (injection, denosumab, 1 mg), 3,660 times for 39 patients. In total Cory E Rathgeber billed 16,516 services in 79 codes, and Medicare paid $317K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-04-18.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 3,660 | 39 | $20.42 | $75K |
| Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 1,850 | 18 | $0.10 | $193 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 827 | 456 | $11.33 | $9,369 |
| 99214 Office E&M - Established | Office | 785 | 461 | $46.29 | $36K |
| 99213 Office E&M - Established | Office | 581 | 363 | $44.05 | $26K |
| 99308 SNF E&M | Office | 326 | 125 | $41.19 | $13K |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 204 | 30 | $0.65 | $133 |
| G0008 Administration of influenza virus vaccine | Office | 199 | 195 | $31.28 | $6,225 |
| 90662 Vaccine Product | Office | 194 | 190 | $81.31 | $16K |
| 96372 Injection Administration | Office | 163 | 62 | $9.31 | $1,518 |
| 90480 Vaccine Administration | Office | 109 | 107 | $41.50 | $4,524 |
| 91320 Vaccine Product | Office | 108 | 106 | $150.08 | $16K |
| 93000 Electrocardiogram | Office | 46 | 46 | $10.53 | $484 |
| 99495 Chronic, Principal, and Transitional Care Management | Office | 44 | 42 | $73.14 | $3,218 |
| 20610 Joint Injection | Office | 42 | 27 | $46.17 | $1,939 |
By year: 2022 $247K for 11,783 services; 2023 $263K for 11,159 services; 2024 $317K for 16,516 services.
Medicare prescription drug claims, 2024
In 2024, the drug Cory E Rathgeber prescribed most often to Medicare patients was Atorvastatin Calcium, with 1,199 prescriptions and refills. In total Cory E Rathgeber wrote 26,896 Medicare prescriptions that cost $1.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 1,199 | 2,189 | 205 | $10K |
| Levothyroxine Sodium Generic | 1,161 | 2,071 | 181 | $14K |
| Amlodipine Besylate Generic | 1,138 | 2,096 | 199 | $6,564 |
| Metoprolol Succinate Generic | 1,044 | 1,848 | 173 | $13K |
| Furosemide Generic | 983 | 1,201 | 108 | $5,095 |
| Losartan Potassium Generic | 910 | 1,916 | 187 | $9,209 |
| Lisinopril Generic | 781 | 1,331 | 123 | $4,963 |
| Omeprazole Generic | 768 | 1,358 | 141 | $6,612 |
| Pantoprazole Sodium Generic | 681 | 996 | 87 | $13K |
| Rosuvastatin Calcium Generic | 671 | 1,392 | 149 | $10K |
| Tamsulosin Hcl Generic | 655 | 1,287 | 126 | $11K |
| Gabapentin Generic | 605 | 725 | 65 | $5,577 |
| Hydrochlorothiazide Generic | 547 | 1,212 | 111 | $3,273 |
| Eliquis Apixaban | 537 | 623 | 62 | $268K |
| Allopurinol Generic | 468 | 769 | 68 | $4,318 |
Brand drugs: 3,970 claims; generic drugs: 22,626 claims; opioid claims: 1,000.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Cory E Rathgeber $817 ($817 in general payments such as food, travel and fees) from 15 companies. The largest payer was Amgen Inc. with $180.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 13 | $180 |
| Pfizer Inc. PFE | 13 | $168 |
| Abbvie Inc. ABBV | 13 | $147 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 4 | $62.71 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 3 | $47.25 |
| E.R. Squibb & Sons, L.L.C. BMY | 2 | $41.32 |
| Neurocrine BioSciences, Inc. NBIX | 2 | $32.77 |
| Astellas Pharma US Inc 4503.T | 1 | $22.17 |
| Verona Pharma, Inc. VRNA | 1 | $21.77 |
| Axsome Therapeutics, Inc. AXSM | 1 | $18.27 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.